SCHEMBL13660609

SCHEMBL13660609

CC(C)(C)OC(=O)N1CCC(Nc2ccc([C@H]3CC[C@H]4CCCCN43)cc2)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.60
NPC1 O15118 2/20 0.59
RAB9A P51151 2/20 0.59
MAPT P10636 2/20 0.59
MAPK1 P28482 1/20 0.59
HTT P42858 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
EPHX1 P07099 1/20 0.46
PTPN2 P17706 1/20 0.46
PTPN1 P18031 1/20 0.46
PTPN6 P29350 1/20 0.46
ABL1 P00519 1/20 0.45
RIN1 Q13671 1/20 0.45
NAMPT P43490 1/20 0.45
GPR119 Q8TDV5 3/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
FPR2 P25090 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8647974 0.80 GPR119 (0.54) EPHX1PTPN2PTPN1PTPN6NAMPT
SCHEMBL17554400 0.78 ALDH1A1 (0.77) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL10210061 0.78 ALDH1A1 (0.79) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL4115820 0.78 ALDH1A1 (0.77) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL13660610 0.77 HRH3 (0.47) ALDH1A1FPR2
SCHEMBL23064601 0.77 GPR119 (0.55) PTPN2PTPN1PTPN6NAMPTGPR119
SCHEMBL2873727 0.77 ALDH1A1 (0.75) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL7038173 0.77 ALDH1A1 (0.75) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL377801 0.77 ALDH1A1 (0.75) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL2338130 0.77 ALDH1A1 (0.77) ALDH1A1NPC1RAB9AMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090263322-A1 OCTAHYDRO-INDOLIZINE AND QUINOLIZINE AND HEXAHYDRO-PYRROLIZINES APODACA RICHARD 2009-10-22 US disclosed
US-20090263322-A1 OCTAHYDRO-INDOLIZINE AND QUINOLIZINE AND HEXAHYDRO-PYRROLIZINES APODACA RICHARD 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090263322-A1 OCTAHYDRO-INDOLIZINE AND QUINOLIZINE AND HEXAHYDRO-PYRROLIZINES HRH4, HNMT, HRH1 ALDH1A1 2994/4885NPC1 1655/4885RAB9A 2371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.